• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Stephen Robinson, Anthony H. Goldstone, +5 authors Norbert Schmitz
  • Medicine
  • Blood
  • 2002 (First Publication: 15 December 2002)
  • We report the outcome of reduced-intensity allogeneic progenitor cell transplantation (alloPCT) for 188 patients with lymphoma from the Working Party Lymphoma of the European Group for Blood and BoneExpand
  • Antonio Palumbo, Michele Cavo, +29 authors Mario Boccadoro
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2011 (First Publication: 10 March 2011)
  • PURPOSE In patients with myeloma, thalidomide significantly improves outcomes but increases the risk of thromboembolic events. In this randomized, open-label, multicenter trial, we compared aspirinExpand
  • Anna Sureda, Stephen D Robinson, +11 authors Norbert Schmitz
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2008 (First Publication: 20 January 2008)
  • PURPOSE To compare the clinical outcome in terms of nonrelapse mortality (NRM), relapse rate (RR), overall survival (OS), and progression-free survival (PFS) in patients with relapsed Hodgkin'sExpand
  • Michele Cavo, Lucia Pantani, +27 authors Antonio Palumbo
  • Medicine
  • Blood
  • 2012 (First Publication: 5 July 2012)
  • In a randomized, phase 3 study, superior complete/near-complete response (CR/nCR) rates and extended progression-free survival were demonstrated with bortezomib-thalidomide-dexamethasone (VTD) versusExpand
  • Corrado Girmenia, Anna Maria Raiola, +39 authors Anna Locasciulli
  • Medicine
  • Biology of blood and marrow transplantation…
  • 2014 (First Publication: 1 June 2014)
  • Epidemiologic investigation of invasive fungal diseases (IFDs) in allogeneic hematopoietic stem cell transplantation (allo-HSCT) may be useful to identify subpopulations who might benefit fromExpand
  • U. Vitolo, A. Chiappella, +21 authors G. Rossi
  • Medicine
  • The Lancet. Oncology
  • 2014 (First Publication: 1 June 2014)
  • BACKGROUND Up to 40% of elderly patients with untreated diffuse large B-cell lymphoma (DLBCL) given a regimen of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone every 21 daysExpand
  • Massimo Federico, Stefano Luminari, +17 authors Maura Brugiatelli
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2013 (First Publication: 20 April 2013)
  • PURPOSE Although rituximab (R) is commonly used for patients with advanced follicular lymphoma (FL) requiring treatment, the optimal associated chemotherapy regimen has yet to be clarified. Expand